Ophidion, Inc.

OPHIDION, INC is developing a new class of safe and effective drugs targeting some of the most important receptors in the central nervous system. They are targeting relief of the symptoms of schizophrenia, ADHD, Parkinson’s disease, and Alzheimer’s disease, as well as addiction and anxiety. The founder launched the company in the Pasadena Bioscience Collaborative and located at TechVentures when she joined the Lehigh University faculty.